Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 389

    1.

    Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers.

    Dam EB, Loog M, Christiansen C, Byrjalsen I, Folkesson J, Nielsen M, Qazi AA, Pettersen PC, Garnero P, Karsdal MA.

    Arthritis Res Ther. 2009;11(4):R115. Epub 2009 Jul 24.

    PMID:
    19630944
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.

    Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C.

    Osteoarthritis Cartilage. 2009 Mar;17(3):384-9. Epub 2008 Sep 3.

    PMID:
    18768336
    [PubMed - indexed for MEDLINE]
    4.

    Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study.

    Garnero P, Peterfy C, Zaim S, Schoenharting M.

    Arthritis Rheum. 2005 Sep;52(9):2822-9.

    PMID:
    16145678
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.

    Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H, Peterfy C, Burlet N, Ethgen D, Montague T, Dabrowski C, Reginster JY.

    Ann Rheum Dis. 2006 Aug;65(8):1050-4. Epub 2006 Jan 5.

    PMID:
    16396978
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.

    Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD.

    Arthritis Rheum. 2002 Oct;46(10):2613-24.

    PMID:
    12384919
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.

    Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E.

    Ann Rheum Dis. 2001 Jun;60(6):619-26.

    PMID:
    11350852
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.

    Garnero P, Aronstein WS, Cohen SB, Conaghan PG, Cline GA, Christiansen C, Beary JF, Meyer JM, Bingham CO 3rd.

    Osteoarthritis Cartilage. 2008 Jun;16(6):660-6. Epub 2007 Nov 13.

    PMID:
    17993283
    [PubMed - indexed for MEDLINE]
    9.

    A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.

    Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P.

    Rheumatology (Oxford). 2007 Jun;46(6):938-43. Epub 2007 Mar 26.

    PMID:
    17387119
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.

    Abadie E, Ethgen D, Avouac B, Bouvenot G, Branco J, Bruyere O, Calvo G, Devogelaer JP, Dreiser RL, Herrero-Beaumont G, Kahan A, Kreutz G, Laslop A, Lemmel EM, Nuki G, Van De Putte L, Vanhaelst L, Reginster JY; Group for the Respect of Excellence and Ethics in Science.

    Osteoarthritis Cartilage. 2004 Apr;12(4):263-8. Review.

    PMID:
    15023377
    [PubMed - indexed for MEDLINE]
    11.

    Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study.

    Cibere J, Zhang H, Garnero P, Poole AR, Lobanok T, Saxne T, Kraus VB, Way A, Thorne A, Wong H, Singer J, Kopec J, Guermazi A, Peterfy C, Nicolaou S, Munk PL, Esdaile JM.

    Arthritis Rheum. 2009 May;60(5):1372-80.

    PMID:
    19404937
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.

    Garnero P, Landewé R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, Van Der Heijde D, Boonen A, Geusens P.

    Arthritis Rheum. 2002 Nov;46(11):2847-56.

    PMID:
    12428224
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.

    Landewé R, Geusens P, Boers M, van der Heijde D, Lems W, te Koppele J, van der Linden S, Garnero P.

    Arthritis Rheum. 2004 May;50(5):1390-9.

    PMID:
    15146408
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey.

    Tanishi N, Yamagiwa H, Hayami T, Mera H, Koga Y, Omori G, Endo N.

    J Bone Miner Metab. 2009;27(5):605-12. Epub 2009 Apr 21.

    PMID:
    19381754
    [PubMed - indexed for MEDLINE]
    16.

    A new marker for osteoarthritis: cross-sectional and longitudinal approach.

    Reijman M, Hazes JM, Bierma-Zeinstra SM, Koes BW, Christgau S, Christiansen C, Uitterlinden AG, Pols HA.

    Arthritis Rheum. 2004 Aug;50(8):2471-8.

    PMID:
    15334460
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes.

    Raynauld JP, Martel-Pelletier J, Berthiaume MJ, Beaudoin G, Choquette D, Haraoui B, Tannenbaum H, Meyer JM, Beary JF, Cline GA, Pelletier JP.

    Arthritis Res Ther. 2006;8(1):R21. Epub 2005 Dec 30.

    PMID:
    16507119
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis.

    Garnero P, Charni N, Juillet F, Conrozier T, Vignon E.

    Ann Rheum Dis. 2006 Dec;65(12):1639-44. Epub 2006 Mar 28.

    PMID:
    16569684
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Collagen type II C-telopeptide fragments as an index of cartilage degradation.

    Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P.

    Bone. 2001 Sep;29(3):209-15.

    PMID:
    11557363
    [PubMed - indexed for MEDLINE]
    20.

    Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.

    Young-Min S, Cawston T, Marshall N, Coady D, Christgau S, Saxne T, Robins S, Griffiths I.

    Arthritis Rheum. 2007 Oct;56(10):3236-47.

    PMID:
    17907159
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk